Finance

Lists
OSE:EPA
Ose Immunotherapeutics SA
2,07 €
-1,43%
(-0,030) 1D
21-окт., 17:35:09 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
2,10 €
High
2,11 €
Low
2,05 €
Mkt. cap
50,31 млн
Avg. vol.
143,21 миң
Volume
74,99 миң
52-wk high
6,48 €
52-wk low
2,01 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
Open
2,10 €
High
2,11 €
Low
2,05 €
Mkt. cap
50,31 млн
Avg. vol.
143,21 миң
Volume
74,99 миң
52-wk high
6,48 €
52-wk low
2,01 €
EPS
-1,69 €
Shares outstanding
23,56 млн
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded2004-ж., 17-ноя.
Headquarters-
Sector-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2024-ж. сен.
2024-ж. дек.
Revenue
431,00 миң
431,00 миң
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 млн
8,28 млн
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 млн
1,08 млн
Operating expense
10,22 млн
10,22 млн
Total operating expenses
10,22 млн
10,22 млн
Operating income
-9,79 млн
-9,79 млн
Other non operating income
-611,00 миң
-611,00 миң
EBT including unusual items
-10,44 млн
-10,44 млн
EBT excluding unusual items
-10,53 млн
-10,53 млн
Income tax expense
-576,50 миң
-576,50 миң
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 миң
41,00 миң
Net income
-9,86 млн
-9,86 млн
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 миң
571,00 миң
Interest expense
-707,50 миң
-707,50 миң
Net interest expenses
-136,50 миң
-136,50 миң
Depreciation and amortization charges
-
-
EBITDA
-9,74 млн
-9,74 млн
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору